Galectin Therapeutics Inc (OQ:GALT)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for GALT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -18,638  
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -46,875  
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,638 $4.72
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 46,875 $2.39
Feb 10/20 Feb 9/20 Lewis Joel Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Feb 10/20 Feb 9/20 Lewis Joel Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $2.39
Jan 21/20 Jan 17/20 10X Fund, L.P. Direct Ownership Common Stock S - Open market or private sale -10,000 $2.97
Jan 13/20 Jan 9/20 Uihlein Richard E Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 45,000  
Jan 13/20 Jan 9/20 Uihlein Richard E Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 12,238 $2.86
Jan 13/20 Jan 9/20 Lewis Joel Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 40,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GALT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -18,638  
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -46,875  
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,638 $4.72
Feb 14/20 Feb 13/20 Uihlein Richard E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 46,875 $2.39
Feb 13/20 Oct 23/19 Czirr James C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -125,000  
Feb 13/20 Sep 30/19 Czirr James C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 1,000 $6.00
Feb 13/20 Nov 18/19 10X Fund, L.P. Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -9,350  
Feb 10/20 Feb 9/20 Lewis Joel Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Feb 10/20 Feb 9/20 Lewis Joel Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $2.39
Jan 21/20 Jan 17/20 10X Fund, L.P. Direct Ownership Common Stock S - Open market or private sale -10,000 $2.97
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $GALT